HopeStage
Study directory

Bipolarity studies

Compare studies and check their requirements with the research team.

Back to overview
More filters: keywords, city, remote
78studies shown
Showing 1-12 of 78
Drug study icon
RecruitingNCT06929273

KarXT for manic episodes in bipolarity type I

The registry lists this study as recruiting. Study locations are listed in the United States, in Australia, in France, ...

In Australia
Why is this study shown?

This study is directly about Bipolarity.

BipolarityDrugA study involving a medication or substance.From 18 Years to 65 Years
Countries
United States, Australia, France, ...
Sponsor
Bristol-Myers Squibb
Condition
Bipolarity
Drug study icon
RecruitingNCT06951698

KarXT for manic episodes in bipolarity type I

The registry lists this study as recruiting. Study locations are listed in the United States, in Australia, in New Zealand, ...

In Australia
Why is this study shown?

This study is directly about Bipolarity.

BipolarityDrugFrom 18 Years to 65 Years
Countries
United States, Australia, New Zealand, ...
Sponsor
Bristol-Myers Squibb
Condition
Bipolarity
Other study type icon
RecruitingACTRN12614000409673

MoodSwings: An Online Self Help Program for Bipolarity

The registry describes this research topic: “MoodSwings: An Online Self Help Program for bipolarity”. This is an interventional study.

Remote / online
Why is this study shown?

This study is directly about Bipolarity.

BipolarityOtherFrom 21 Years to 65 Years
Countries
United States, Australia
Sponsor
University of Melbourne
Condition
Bipolarity
Drug study icon
Not Yet RecruitingACTRN12625000328471

INTENSIFY Trial: The Effect of a Six-Week Intensified Pharmacological Treatment (Third-Line Medication) for Bipolarity

This study is not yet recruiting in Australia. It is testing INTENSIFY Trial: The Effect of a Six-Week Intensified Pharmacological Treatment (Third-Line Medication) for Bipolarity.

In Australia
Why is this study shown?

This study is directly about Bipolarity.

BipolarityDrugFrom 18 Years to 65 Years
Countries
Australia
Sponsor
The University of Adelaide
Condition
Bipolarity
Drug study icon
RecruitingACTRN12625000942459

A crossover study to investigate the safety, tolerability, pharmacokinetics, relative bioavailability, and pharmacodynamics of single doses of Katamine immediate release (KET-IR) and Ketamine abuse deterrent (KET-AD) oral ketamine capsules in healthy volunteers.

The registry lists this study as recruiting. Study locations are listed in Australia.

In Australia
Why is this study shown?

This study is directly about Bipolarity.

BipolarityDrugFrom 18 Years to 55 Years
Countries
Australia
Sponsor
Novotech (Australia) Pty Limited
Condition
Bipolarity
Drug study icon
CompletedNCT00190892

Olanzapine Plus Carbamazepine in the Treatment of Bipolar I Mania

This summary needs review. Please check the official study record and contact the research team for details.

In Australia
Why is this study shown?

This study is directly about Bipolarity.

BipolarityDrugFrom 18 Years to 65 Years
Countries
Australia, Greece, Hungary, ...
Sponsor
Eli Lilly and Company
Condition
Bipolarity
Drug study icon
TerminatedACTRN12616001702404

Efficacy of Lithium versus Lamotrigine for Bipolarity type II

The registry describes this research topic: “Efficacy of Lithium versus Lamotrigine for the treatment of type II bipolarity”. This is an interventional study.

In Australia
Why is this study shown?

This study is directly about Bipolarity.

BipolarityDrugFrom 18 Years to 65 Years
Countries
Australia
Sponsor
Professor Gordon Parker
Condition
Bipolarity
Other study type icon
CompletedACTRN12617000840381

Enhancing decision-making about treatment in Bipolarity type II: Evaluation of a treatment decision-aid for patients and their family.

The registry describes this research topic: “Enhancing decision-making about treatment in type II bipolarity: Evaluation of a treatment decision-aid for patients and their family”. This is an interventional study.

In Australia
Why is this study shown?

This study is directly about Bipolarity.

BipolarityOtherFrom 18 Years to 65 Years
Countries
Australia
Sponsor
A/Prof Ilona Juraskova
Condition
Bipolarity
Drug study icon
CompletedACTRN12622000669796

Intranasal insulin for neurocognition in Bipolarity

The registry describes this research topic: “Intranasal insulin for neurocognition in bipolarity”. This is an interventional study.

In Australia
Why is this study shown?

This study is directly about Bipolarity.

BipolarityDrugFrom 18 Years to 55 Years
Countries
Australia
Sponsor
Swinburne University of Technology
Condition
Bipolarity
Data coverage

Public registry coverage is progressing

HopeStage gathers information about mental health clinical trials from the public registries we currently index. We are progressively improving registry coverage, but this does not mean that every study in the world is already included.